Percutaneous extracorporeal life support for patients in therapy refractory cardiogenic shock: initial results of an interdisciplinary team

S. Guenther, Nawid Khaladj(München Klinik), Stefan M. Sattler(University of Copenhagen), Maximilian Pichlmaier(LMU Klinikum), Matthias Fischer(Alb Fils Kliniken), Sven Peterß(LMU Klinikum), Hans Theiß(Ludwig-Maximilians-Universität München), Steffen Maßberg(German Centre for Cardiovascular Research), C. Hagl(Ludwig-Maximilians-Universität München), F. Born(LMU Klinikum)
Interactive Cardiovascular and Thoracic Surgery
December 13, 2013
10.1093/icvts/ivt505
Cited by 63

Related Papers

Interplay between inflammation and thrombosis in cardiovascular pathology
|Nature Reviews Cardiology|2021|940
Guided de-escalation of antiplatelet treatment in patients with acute coronary syndrome undergoing percutaneous coronary intervention (TROPICAL-ACS): a randomised, open-label, multicentre trial
|The Lancet|2017|588
Immunothrombotic Dysregulation in COVID-19 Pneumonia Is Associated With Respiratory Failure and Coagulopathy
|Circulation|2020|570
Synergy between CD26/DPP-IV Inhibition and G-CSF Improves Cardiac Function after Acute Myocardial Infarction
|Cell stem cell|2009|299
Height alone, rather than body surface area, suffices for risk estimation in ascending aortic aneurysm
|Journal of Thoracic and Cardiovascular Surgery|2017|278